Literature DB >> 19902166

[Severe aseptic leucoencephalopathy. Manifested as immune reconstitution inflammatory syndrome in Caucasian and African patients].

A Ringelstein1, C Oelschlaeger, G Arendt, C Mathys, R Dziewas, T Niederstadt, D Reichelt, M Hasselblatt, I W Husstedt, A Saleh.   

Abstract

BACKGROUND: We hypothesize that CNS immune reconstitution inflammatory syndrome (IRIS) after highly active antiretroviral therapy (HAART) in HIV-1-positive patients may become manifest without any opportunistic infection as an aseptic leucoencephalopathy. This opens a window of opportunity for successful treatment with corticosteroids.
DESIGN: We describe a case series of immunocompromised HIV-1-positive patients who were started on HAART. All of them had clinical laboratory follow-up tests and cerebral MRI in order to investigate the course and the underlying pathophysiology of this aseptic form of IRIS. One African patient died and we performed a neuropathological examination.
RESULTS: No infectious agent was detected before and during HAART. Three of four immunocompromised patients were successfully treated with corticosteroids while HAART was never interrupted and have survived up to now. One African patient died within 2 days despite intensive care due to cerebral oedema.
CONCLUSIONS: Starting HAART, HIV-1-positive patients may develop an aseptic type of IRIS of the CNS without any detectable opportunistic infection, a finding that has not yet been published. This makes them susceptible for successful treatment with corticosteroids. Perhaps IRIS has a higher incidence in African patients and the patients have a poorer outcome than Caucasians.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19902166     DOI: 10.1007/s00115-009-2839-5

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  18 in total

Review 1.  Therapy Insight: CNS manifestations of HIV-associated immune reconstitution inflammatory syndrome.

Authors:  David J Riedel; Carlos A Pardo; Justin McArthur; Avindra Nath
Journal:  Nat Clin Pract Neurol       Date:  2006-10

2.  Guillain--Barre syndrome following immune reconstitution after antiretroviral therapy for primary HIV infection.

Authors:  E C Y Teo; A Azwra; R L Jones; Brian G L Gazzard; Mark Nelson
Journal:  J HIV Ther       Date:  2007-09

3.  Suspected immune reconstitution inflammatory syndrome associated with the proliferation of Kaposi's sarcoma during HAART.

Authors:  Ramesh V Nathan
Journal:  AIDS       Date:  2007-03-30       Impact factor: 4.177

4.  Biomarkers of HIV Immune Reconstitution Inflammatory Syndrome.

Authors:  Shuli Bonham; David B Meya; Paul R Bohjanen; David R Boulware
Journal:  Biomark Med       Date:  2008       Impact factor: 2.851

Review 5.  Immune restoration inflammatory syndromes: apparently paradoxical clinical events after the initiation of HAART.

Authors:  Matthias Stoll; Reinhold E Schmidt
Journal:  Curr HIV/AIDS Rep       Date:  2004-09       Impact factor: 5.071

6.  Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases.

Authors:  Patricia Price; Grant Morahan; Dexing Huang; Emma Stone; Karey Y M Cheong; Alison Castley; Marina Rodgers; Meredith Q McIntyre; Lawrence J Abraham; Martyn A French
Journal:  AIDS       Date:  2002-10-18       Impact factor: 4.177

7.  Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy.

Authors:  Samuel A Shelburne; Fehmida Visnegarwala; Jorge Darcourt; Edward A Graviss; Thomas P Giordano; A Clinton White; Richard J Hamill
Journal:  AIDS       Date:  2005-03-04       Impact factor: 4.177

8.  Changing incidence of central nervous system diseases in the EuroSIDA cohort.

Authors:  Antonella d'Arminio Monforte; Paola Cinque; Amanda Mocroft; Frank-Detlev Goebel; Francisco Antunes; Christine Katlama; Ulrik Stenz Justesen; Stefano Vella; Ole Kirk; Jens Lundgren
Journal:  Ann Neurol       Date:  2004-03       Impact factor: 10.422

9.  PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids.

Authors:  K Tan; R Roda; L Ostrow; J McArthur; A Nath
Journal:  Neurology       Date:  2009-01-07       Impact factor: 9.910

10.  Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study.

Authors:  David M Murdoch; Willem D F Venter; Charles Feldman; Annelies Van Rie
Journal:  AIDS       Date:  2008-03-12       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.